Apply on Employer Site

Pfizer · 1 day ago

Director, Global Access Strategy & Pricing, Oncology Pipeline & BD

New York, NY

Full-time

Hybrid

Director/Executive

$170K/yr - $283K/yr

8+ years exp

Pfizer is a leading pharmaceutical company, and they are seeking a Director of Global Access Strategy & Pricing for their Oncology Pipeline & Business Development. This role involves developing market access and pricing strategies for early clinical and business development opportunities, as well as synthesizing global payer insights to inform access strategies and pricing recommendations.

BiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine

No H1B

U.S. Citizen Only

Responsibilities

Provide payer insights to understand/meet the needs of all types of payers in key Pfizer markets and develop an overarching Access Strategy

Represent the ‘Voice of the Payer’ at cross-functional team and governance bodies for pre-POC priority assets

Deliver clear recommendations relating to payer strategy, pricing and reimbursement needs, evidence generation, data collection and value proposition via the Integrated Value & Access Strategy (IVAS)

Achieving the above will require the formation of leadership and/or participation in virtual cross functional Access Matric Teams (AMT). When necessary, convene and coordinate taskforce deployments related to specific asset threats and opportunities

Lead horizon scanning and in-depth understanding of payer regulations, needs of all types of payers (e.g. HTA agencies, institutions and patients) in key Pfizer markets

Create and maintain expertise in payer regulation and priorities across major countries / archetypes in the region:

Assessment and communication of external access trends to anticipate potential challenges and opportunities for pipeline & inline portfolio

Gather and synthesize feedback for development programs with health technology assessment agencies, payers, and relevant patient associations within assigned region

Collaborate with Commercial Strategy, Clinical and Medical teams to optimize clinical trial designs which incorporate payer requirements for pricing and reimbursement

Provide price and market access input on early clinical trials and generate access recommendations to key business decision points

Anticipate and navigate key external policy changes and trends (e.g. IRA, EU HTA) to ensure future-proofing of our early access strategies

Support development and regional customization of the access strategy and delivery of the payer value proposition

Guide the organization on the payer evidence strategy (by payer archetype) and its incorporation in the asset development program, including endpoint recommendations in trials

Refine deliverables by payer archetypes within assigned region

Identify novel strategies such as novel PRO strategies, VBAs, RWE, etc. to communicate and boost value of upcoming pipeline assets

Work with cross-functional teams including Global HV&E, Clinical, Medical, Commercial Strategy to identify and appropriately allocate resources per critical business needs

Develop and manage stakeholder relationship with Oncology Clinical Team, Global Product Team and R&D Team to shape Pfizer investment decisions for clinical trials design considering key payer requirements (e.g. Germany, France, etc)

Work efficiently and collaboratively in a highly matrixed environment

Set the ambition and vision for value-based access to medicines for strategic assets

Champion the payer agenda internally and improve understanding of payer needs

Develop effective processes and ways of working to support collaboration with key internal stakeholder groups such as medical and health outcomes

Identify new opportunities for value creation based on an understanding of health care systems and the potential benefits of Pfizer medicines

Support development of innovative approaches to evidence generation which meet payer needs and integrate these with the needs of other customers

Ability to manage earnings growth risk due to threats such as competitor pricing, payer policy changes, and the success of replacement earnings through new launches (securing price and reimbursement)

Ability to help patients do more, feel better and live longer amidst a challenging macroeconomic environment and barriers to access

The overall revenue which can be achieved from the R&D organization by optimizing the value that can be created from the medicines in the pipeline

Qualification

Market Access StrategyPricing StrategiesPayer InsightsHealthcare Systems KnowledgeDrug Development ProcessHealth EconomicsPharmaceutical Business LeadershipStakeholder ManagementCross-functional CollaborationLeadership SkillsCommunication Skills

Required

Bachelor's Degree minimum required

8 years' experience minimum required, preferably in healthcare environment, preferably pharmaceutical industry or related consulting services, sufficient to have developed a deep understanding of the global payer and market access environment

Experience in developing and executing Pricing & Market Access strategies and deliverables on key ex-US market such as Germany, France, UK, Italy and/or Spain

Knowledge and understanding of drug development process

Pharmaceutical business leadership, including experience in strategy development and interaction with customers

Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers, develop and coach others, oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact